Variables | Variable | Effective n (%) |
|
|
CRP | Neg | 25 (16.7) |
|
|
15 - 100 | 104 (69.3) |
|
| |
>100 | 21 (14) |
|
| |
Aspect CSF | Cloudy | 55 (36.7) |
|
|
Clair | 95 (65.3) |
|
| |
Pleocytose | <10 | 90 (60) |
|
|
10 - 99 | 23 (15.3) |
|
| |
≥100 | 37 (24.7) |
|
| |
Hospitalisation duration | 1 à 3 days | 37 (24.7) |
|
|
4 à 10 days | 60 (40) |
|
| |
11 à 20 days | 37 (24.7) |
|
| |
≥21 days | 16 (10.6) |
|
| |
Identified pathogens | Bacteria | 25 (16.7) |
|
|
Virus | 9 (6) |
|
| |
Coinfection virus-bacteria | 3 (2) |
|
| |
Aseptic | 113 (75.3) |
|
| |
|
|
| CRP ≥ 20 mg/dl | GB ≥ 10,000 |
RT/PCR of CSF | Haemophilus Influenzae (n = 6) | 14 (9.3) | 6 (100) | 6 (100) |
Streptococcus Pneumoniae (n = 14) | 6 (4) | 14 (100) | 14 (100) | |
Streptococcus agalactiae (n = 5) | 5 (3.3) | 5 (100) | 5 (100) | |
CMV (n = 5) | 5 (3.3) | 4 (80) | 5 (100) | |
Herpes Virus (n = 4) | 4 (2.7) | 3 (75) | 3 (75) | |
CMV+ Pneumococcus pneumoniae (n = 3) | 3 (2) | 3 (100) | 3 (100) | |
Aseptic (n = 113) | 113 (75.3) | 81 (71.7) | 89 (78.8) |